Daré Bioscience Announces Publication of Positive Clinical Findings for Vaginal Administration of Tamoxifen for the Treatment of VVA

Go back to Daré Bioscience Announces Publication of Positive Clinical Findings for Vaginal Administration of Tamoxifen for the Treatment of VVA
(NASDAQ: DARE) Delayed: 2.08 +0.01 (0.48%)
Previous Close $2.07    52 Week High
Open $2.04    52 Week Low
Day High $2.14    P/E N/A 
Day Low $2.00    EPS
Volume 191,534